Scientists hunt for immunotherapy clues in surgical drain fluid
NCT ID NCT05338060
First seen Feb 13, 2026 · Last updated May 13, 2026 · Updated 10 times
Summary
This study collected fluid from surgical drains and blood samples from 10 patients who had surgery for stomach or esophageal cancer. Researchers used lab tests to look for molecular markers that might help predict how well a patient will respond to immunotherapy. The goal was to set up a process for future studies, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.